½ÃÀ庸°í¼­
»óǰÄÚµå
1193235

¸ÞµðÄà Ʈ·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Àü°³º°, Á¾·ùº°, ÃÖÁ¾»ç¿ëÀÚ ½Ã¼³º° - ¼¼°è ±âȸ ºÐ¼®°ú »ê¾÷ ¿¹Ãø(2021-2031³â)

Medical Transcription Software Market By Deployment, By Type, By End User Facilities : Global Opportunity Analysis and Industry Forecast, 2021-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Allied Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 254 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¸ÞµðÄà Ʈ·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2021³â¿¡ 16¾ï 3,174¸¸ ´Þ·¯¸¦ ±â·ÏÇßÀ¸¸ç, 2031³â¿¡´Â 70¾ï 168¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2022-2031³â°£ CAGRÀº 15.5%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå °³¿ä

  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä Á¶»ç °á°ú
    • ÁÖ¿ä ÅõÀÚ Æ÷ÄÏ
  • Porter's Five Forces ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ Æ÷Áö¼Å´×
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • COVID-19 ¿µÇ⠺м®

Á¦4Àå ¸ÞµðÄà Ʈ·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Àü°³º°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • Ŭ¶ó¿ìµå ±â¹Ý
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ¿ÂÇÁ·¹¹Ì½º
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦5Àå ¸ÞµðÄà Ʈ·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Á¾·ùº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • À½¼º ĸó
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • À½¼º ÀνÄ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦6Àå ¸ÞµðÄà Ʈ·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚ ½Ã¼³º°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • º´¿ø¡¤Áø·á¼Ò
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • Áø´Ü ¼¾ÅÍ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
  • ±âŸ
    • ÁÖ¿ä ½ÃÀå µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, ±âȸ
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°
    • ½ÃÀå ºÐ¼® : ±¹°¡º°

Á¦7Àå ¸ÞµðÄà Ʈ·£½ºÅ©¸³¼Ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Áö¿ªº°

  • °³¿ä
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ºÏ¹Ì
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àü°³º°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¾·ùº°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚ ½Ã¼³º°
    • ºÏ¹Ì ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
  • À¯·´
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • À¯·´ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àü°³º°
    • À¯·´ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¾·ùº°
    • À¯·´ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚ ½Ã¼³º°
    • À¯·´ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ±¹°¡º°
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ¿µ±¹
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àü°³º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¾·ùº°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚ ½Ã¼³º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • LAMEA
    • ÁÖ¿ä µ¿Çâ°ú ±âȸ
    • LAMEA ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àü°³º°
    • LAMEA ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¾·ùº°
    • LAMEA ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚ ½Ã¼³º°
    • LAMEA ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ±¹°¡º°
      • ºê¶óÁú
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ±âŸ LAMEA

Á¦8Àå ±â¾÷ »óȲ

  • ¼­·Ð
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÁÖ¿ä 10°³»ç Á¦Ç° ¸ÅÇÎ
  • °æÀï ´ë½Ãº¸µå
  • °æÀï È÷Æ®¸Ê
  • ÁÖ¿ä ¹ßÀü

Á¦9Àå ±â¾÷ °³¿ä

  • 3M Company
  • Amazon Inc
  • Aquity Solutions
  • DeepScribe, Inc.
  • Dolbey System, Inc.
  • Global Medical Transcription
  • iMedX
  • Microsoft Corporation
  • SMARTMD
  • ZyDoc Medical Transcription
KSM 23.03.17

The global medical transcription software market was valued at $1,631.74 million in 2021, and is projected to reach $7,001.68 million by 2031, registering a CAGR of 15.5% from 2022 to 2031. 

Medical transcription, also known as MT, is an allied health profession dealing with the process of transcribing voice-recorded medical reports that are dictated by physicians, nurses, and other healthcare practitioners. Medical reports can be voice files, notes taken during a lecture, or other spoken material. These are dictated over the phone or uploaded digitally via the Internet or through smart phone apps.

Rise in adoption of medical transcription software for digital documentation, increased use of cloud-based medical transcription software, rapid surge in aging population, and subsequent rise in the number of chronic diseases drive the market growth. However, lack of healthcare IT infrastructure in emerging markets, issues relating to software adoption such as workforce training, and increase in concerns regarding the patient data safety & security are expected to impede the market growth. Moreover, huge market potential in the developing regions is expected to offer opportunities for the market growth during the forecast period.

The medical transcription software market is segmented into deployment, type, end user facility, and region. By deployment, the market is categorized into cloud-based and on premises. On the basis of type, the market is segregated into voice capture and voice recognition. By end user facility, the market is classified into hospitals and clinics, diagnostic centers, and others. Others include ambulatory surgical centers and healthcare systems. Hospitals and clinics segment is further segmented into private and public. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major key players that operate in the global medical transcription software market are 3M, Dolbey System, Inc., Global Medical Transcription, DeepScribe, Inc., Microsoft Corporation (Nuance Communication, Inc.), Amazon, Inc. (Amazon Web Services, Inc.), ZyDoc Medical Transcription, SmartMD, AQuity Solutions, and iMedX.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical transcription software market analysis from 2021 to 2031 to identify the prevailing medical transcription software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical transcription software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical transcription software market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Deployment

  • Cloud Based
  • On Premises

By Type

  • Voice Capture
  • Voice Recognition

By End User Facilities

  • Hospitals and Clinics
    • Type
    • Private
    • Public
  • Diagnostic Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • 3M Company
    • Amazon Inc
    • Aquity Solutions
    • DeepScribe, Inc.
    • Dolbey System, Inc.
    • Global Medical Transcription
    • iMedX
    • Microsoft Corporation
    • SMARTMD
    • ZyDoc Medical Transcription

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Cloud Based
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 On Premises
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Voice Capture
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Voice Recognition
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country

CHAPTER 6: MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals and Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
    • 6.2.4 Hospitals and Clinics Medical Transcription Software Market by Type
      • 6.2.4.1 Private Market size and forecast, by region
      • 6.2.4.2 Public Market size and forecast, by region
  • 6.3 Diagnostic Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Deployment
    • 7.2.3 North America Market size and forecast, by Type
    • 7.2.4 North America Market size and forecast, by End User Facilities
      • 7.2.4.1 North America Hospitals and Clinics Medical Transcription Software Market by Type
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Deployment
      • 7.2.5.1.2 Market size and forecast, by Type
      • 7.2.5.1.3 Market size and forecast, by End User Facilities
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Deployment
      • 7.2.5.2.2 Market size and forecast, by Type
      • 7.2.5.2.3 Market size and forecast, by End User Facilities
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Deployment
      • 7.2.5.3.2 Market size and forecast, by Type
      • 7.2.5.3.3 Market size and forecast, by End User Facilities
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Deployment
    • 7.3.3 Europe Market size and forecast, by Type
    • 7.3.4 Europe Market size and forecast, by End User Facilities
      • 7.3.4.1 Europe Hospitals and Clinics Medical Transcription Software Market by Type
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Deployment
      • 7.3.5.1.2 Market size and forecast, by Type
      • 7.3.5.1.3 Market size and forecast, by End User Facilities
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Deployment
      • 7.3.5.2.2 Market size and forecast, by Type
      • 7.3.5.2.3 Market size and forecast, by End User Facilities
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Deployment
      • 7.3.5.3.2 Market size and forecast, by Type
      • 7.3.5.3.3 Market size and forecast, by End User Facilities
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Deployment
      • 7.3.5.4.2 Market size and forecast, by Type
      • 7.3.5.4.3 Market size and forecast, by End User Facilities
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Deployment
      • 7.3.5.5.2 Market size and forecast, by Type
      • 7.3.5.5.3 Market size and forecast, by End User Facilities
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Deployment
      • 7.3.5.6.2 Market size and forecast, by Type
      • 7.3.5.6.3 Market size and forecast, by End User Facilities
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Deployment
    • 7.4.3 Asia-Pacific Market size and forecast, by Type
    • 7.4.4 Asia-Pacific Market size and forecast, by End User Facilities
      • 7.4.4.1 Asia-Pacific Hospitals and Clinics Medical Transcription Software Market by Type
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Deployment
      • 7.4.5.1.2 Market size and forecast, by Type
      • 7.4.5.1.3 Market size and forecast, by End User Facilities
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Deployment
      • 7.4.5.2.2 Market size and forecast, by Type
      • 7.4.5.2.3 Market size and forecast, by End User Facilities
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Deployment
      • 7.4.5.3.2 Market size and forecast, by Type
      • 7.4.5.3.3 Market size and forecast, by End User Facilities
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Deployment
      • 7.4.5.4.2 Market size and forecast, by Type
      • 7.4.5.4.3 Market size and forecast, by End User Facilities
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Deployment
      • 7.4.5.5.2 Market size and forecast, by Type
      • 7.4.5.5.3 Market size and forecast, by End User Facilities
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Deployment
      • 7.4.5.6.2 Market size and forecast, by Type
      • 7.4.5.6.3 Market size and forecast, by End User Facilities
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Deployment
    • 7.5.3 LAMEA Market size and forecast, by Type
    • 7.5.4 LAMEA Market size and forecast, by End User Facilities
      • 7.5.4.1 LAMEA Hospitals and Clinics Medical Transcription Software Market by Type
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Deployment
      • 7.5.5.1.2 Market size and forecast, by Type
      • 7.5.5.1.3 Market size and forecast, by End User Facilities
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Deployment
      • 7.5.5.2.2 Market size and forecast, by Type
      • 7.5.5.2.3 Market size and forecast, by End User Facilities
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Deployment
      • 7.5.5.3.2 Market size and forecast, by Type
      • 7.5.5.3.3 Market size and forecast, by End User Facilities
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Deployment
      • 7.5.5.4.2 Market size and forecast, by Type
      • 7.5.5.4.3 Market size and forecast, by End User Facilities

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 3M Company
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Amazon Inc
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Aquity Solutions
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 DeepScribe, Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Dolbey System, Inc.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Global Medical Transcription
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 iMedX
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Microsoft Corporation
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 SMARTMD
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 ZyDoc Medical Transcription
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦